Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone XR in Rheumatoid Arthritis
NCT00379600Phase 2Completed
- Sponsor
- GSK
- Start
- Nov 2004
- Primary completion
- Dec 2006
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 2 trial of rosiglitazone in rheumatoid arthritis (RA), sponsored by GSK. Started Nov 2004; status: completed.
02
Drugs
rosiglitazone
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00379600.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00379600.